Interim Results of a Phase 2 Clinical Study of Nusinersen (ISIS-SMNRx) in Patients with Infantile-Onset Spinal Muscular Atrophy Finkel, R., Chiriboga, C., Vajsar, J., Day, J., Montes, J., De Vivo, D., Yamashita, M., Rigo, F., Hung, G., Schneider, E., Norris, D., Xia, S., Bennett, F., Bishop, K. LIPPINCOTT WILLIAMS & WILKINS. 2016

View details for Web of Science ID 000411328605106